Michael Houghton
Patrimonio netto: 87 991 $ in data 30/06/2026
Patrimonio netto: 87 991 $ in data 30/06/2026
Michael Houghton is currently Chairman-Virology & Professor at the University of Alberta since 2010.
Dr. Houghton is Director at the Li Ka Shing Institute of Virology.
Dr. Houghton is Independent Director at Assembly Biosciences, Inc. since 2021.
Dr. Houghton is Director at Achlys, Inc., Prophysis, Inc., Aurora Vaccines, Inc., Heka Therapeutics, Inc., and Egerio, Inc. Formerly, Dr. Houghton was Vice President-Hepatitis C & Virology Research at Novartis Vaccines & Diagnostics, Inc. Dr. Houghton was Chief Scientific Officer at Epiphany Biosciences, Inc. from 2007 to 2009.
Dr. Houghton was Professor at the University of Alberta.
Dr. Houghton completed undergraduate studies at the University of East Anglia and earned a doctorate from King's College London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 3.202 ( 0,02% ) | 87 991 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 19/07/2021 |
Li Ka Shing Institute of Virology
Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to develops hepatitis vaccines and antiviral therapies | Direttore/Membro del Consiglio | - |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2010 |
Achlys, Inc. | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Direttore Tecnico/Scientifico/R&S | 01/01/2009 |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Health Technology |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of East Anglia
University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Li Ka Shing Institute of Virology
Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to develops hepatitis vaccines and antiviral therapies | Commercial Services |
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Achlys, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale